Answers are grounded in this paper and cite their sources.
Objective Pancreatic cancer (PC) is highly lethal and resistant to current therapies, underscoring the need for novel strategies that target regulated cell death. This study aimed to evaluate the anti-PC efficacy of total secondary saponins (TSS) from Anemone raddeana and elucidate the mechanism by which TSS induces pyroptosis. Methods TSS components were characterized by mass spectrometry. Anti-tumor effects were assessed in vitro using human pancreatic cancer cell lines (PANC-1 and AsPC-1 cells) and in vivo (xenograft mouse model). Integrated multi-omics analyses (network pharmacology, proteomics, metabolomics, bioinformatics) identified core components, targets, and pathways. Key findings were validated by molecular docking, immunohistochemistry, and Western blotting. Results Mass spectrometry identified 17 C-3 monosaccharide triterpenoid saponins in TSS. Both in vitro and in vivo models confirmed that TSS can significantly inhibit PC cell proliferation by inducing pyroptosis through the Caspase-3/gasdermin E (GSDME) pathway. Multi-omics highlighted hederacolchiside A1 as a core compound and revealed its regulation of inflammation, proliferation, and oxidative stress through the phosphoinositide 3-kinase/protein kinase B (PI3K/Akt) and nuclear factor- κ B (NF- κ B) signaling pathways. Molecular docking and Western blotting analysis confirmed activation of downstream pyroptosis mechanisms. Conclusion This study demonstrates that TSS suppresses PC progression by regulating Caspase-3/GSDME-mediated pyroptosis through modulation of PI3K/Akt and NF- κ B signaling pathways, supporting its potential as a novel therapeutic candidate for PC.
No takes yet. Share an insight, caveat, or question.
Han et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: